Regenovue Fine Plus is a sterile, resorbable dermal filler based on non-animal derived, cross-linked hyaluronic acid. It is developed for professional practitioners seeking a reliable option for the correction of fine lines, early wrinkles, and superficial skin irregularities. The formulation is optimised for controlled flow and even distribution within the superficial dermis, supporting natural-looking outcomes without excessive volume. This product is commonly selected for early intervention treatments where subtle refinement is required rather than structural volume replacement. Its rheological properties allow for precise placement in delicate areas such as perioral lines, superficial facial lines, and early signs of cutaneous ageing. Regenovue Fine Plus is positioned within treatment plans focused on skin quality improvement and early wrinkle management. Manufactured to meet European medical device standards, Regenovue Fine Plus offers predictable handling characteristics, making it suitable for practitioners who require consistency and accuracy during injection. The hyaluronic acid used is designed to integrate smoothly with surrounding tissue while supporting hydration and temporary wrinkle correction. Results are visible following treatment and gradually diminish as the product is naturally resorbed. Longevity varies depending on treatment area, technique, and individual patient factors. Regenovue Fine Plus is intended for use as part of a comprehensive aesthetic approach, rather than as a standalone corrective solution. How It Works The cross-linked hyaluronic acid attracts and retains water within the superficial dermis. Once placed, it temporarily fills fine lines while supporting hydration and skin smoothness. The gel is gradually broken down by natural metabolic processes. Key Benefits Supports correction of fine lines and early wrinkles Suitable for superficial dermal placement Smooth consistency for controlled injection Non-animal derived hyaluronic acid Temporary, resorbable formulation